Correlation Between Zentalis Pharmaceuticals and Nautilus Biotechnology
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Nautilus Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Nautilus Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Nautilus Biotechnology, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Nautilus Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Nautilus Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Nautilus Biotechnology.
Diversification Opportunities for Zentalis Pharmaceuticals and Nautilus Biotechnology
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Zentalis and Nautilus is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Nautilus Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nautilus Biotechnology and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Nautilus Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nautilus Biotechnology has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Nautilus Biotechnology go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Nautilus Biotechnology
Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to under-perform the Nautilus Biotechnology. In addition to that, Zentalis Pharmaceuticals is 1.2 times more volatile than Nautilus Biotechnology. It trades about -0.04 of its total potential returns per unit of risk. Nautilus Biotechnology is currently generating about 0.04 per unit of volatility. If you would invest 176.00 in Nautilus Biotechnology on August 25, 2024 and sell it today you would earn a total of 64.00 from holding Nautilus Biotechnology or generate 36.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Nautilus Biotechnology
Performance |
| Timeline |
| Zentalis Pharmaceuticals |
| Nautilus Biotechnology |
Zentalis Pharmaceuticals and Nautilus Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zentalis Pharmaceuticals and Nautilus Biotechnology
The main advantage of trading using opposite Zentalis Pharmaceuticals and Nautilus Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Nautilus Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nautilus Biotechnology will offset losses from the drop in Nautilus Biotechnology's long position.| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
| Nautilus Biotechnology vs. C4 Therapeutics | Nautilus Biotechnology vs. Kymera Therapeutics | Nautilus Biotechnology vs. Foghorn Therapeutics | Nautilus Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |